StockNews.AI
PIII
StockNews.AI
145 days

P3 Health Partners Announces Fourth Quarter and Full Year 2024 Results

1. P3 Health Partners reported strong financials and affirmed 2025 guidance. 2. CEO highlights growth in members, revenue, quality outcomes, and provider retention.

Earnings
-4.59%Current Return
VS
-2.01%S&P 500
$0.180803/27 04:36 PM EDTEvent Start
$0.172503/28 10:56 PM EDTLatest Updated
2m saved
Insight
Article

FAQ

Why Bullish?

P3's growth metrics and positive outlook reflect effective operational strategy, similar to previous recessions where healthcare companies thrived amid uncertainty.

How important is it?

The reaffirmation of guidance along with strong financials is likely to attract investors, demonstrating P3's potential for continued growth.

Why Short Term?

Immediate investor confidence likely impacted by strong quarterly results and affirmations for upcoming year may drive short-term stock movement.

Related Companies

UNHCNCHCA
HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient- centered and physician-led population health management company, today announced its financial results for the fourth quarter and full year ended December 31, 2024, and affirmed its 2025 guidance. “Our business model remains fundamentally strong as we continue to deliver member and top-line growth, quality outcomes, and provider retention,” said Aric Coffman, CEO of P3. “With the $130M+.

Related News